Home › Funds › GREAT POINT PARTNERS LLC › CTNM

GREAT POINT PARTNERS LLC position in CTNM

CONTINEUM THERAPEUTICS INC CL A · Health Care

GREAT POINT PARTNERS LLC reported holding 921,481 shares of CTNM (CONTINEUM THERAPEUTICS INC CL A) in its Q2 2026 13F filing — a position valued at US$15.1M, representing 3.17% of its reported portfolio and ranking #14 among its reported holdings. GREAT POINT PARTNERS LLC has disclosed CTNM holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)921.48K sh
Reported value held$15.10M
Portfolio Weight3.17%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How GREAT POINT PARTNERS LLC's CTNM position evolved

GREAT POINT PARTNERS LLC first disclosed a stake in CTNM in Q4 2025 at 800,000 shares (US$9.1M). The position peaked in Q2 2026 at 921,481 shares, worth US$15.1M. Across 3 filings, GREAT POINT PARTNERS LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 921,481 shares valued at US$15.1M — an increase of 121,283 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 800.00K $9.14M New
Q1 2026 800.20K $10.45M Hold
Q2 2026 921.48K $15.10M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CTNM and 13F data

CTNM (CONTINEUM THERAPEUTICS INC CL A) is a Health Care company. 63 other funds we track also report a position in CTNM — the largest reported positions include MONTANOVA CAPITAL, LLC (US$46.6M), JOHNSON & JOHNSON (US$32.4M), Ikarian Capital, LLC (US$13.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CTNM

All CTNM fund holders →

FAQ

How long has GREAT POINT PARTNERS LLC held CTNM?

GREAT POINT PARTNERS LLC has disclosed CTNM holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is GREAT POINT PARTNERS LLC's current position in CTNM?

As of Q2 2026, GREAT POINT PARTNERS LLC holds 921.48K shares of CTNM (CONTINEUM THERAPEUTICS INC CL A), valued at $15.10M, representing 3.17% of its reported portfolio and ranking #14.

Has GREAT POINT PARTNERS LLC been buying or selling CTNM?

In the latest 13F filing (Q2 2026), GREAT POINT PARTNERS LLC increased its position in CTNM. The position peaked in Q2 2026 at 921.48K shares.

Which other funds hold CTNM?

Other major institutional holders of CTNM include MONTANOVA CAPITAL, LLC, JOHNSON & JOHNSON, Ikarian Capital, LLC, among 63 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.